RE: There is a clear business case for AstraZeneca and other large pharma to expand their markets25 Sep 2025 04:15
Steve are you taking over from. EC regurgitating old news?
The problem is that no follow on phase 2 trial has been undertaken or announced nearly 9 months after that news and ANs comments were it would be very quick to sign as the paperwork was mostly already in place from the first phase. The fact no new deal has been penned looks. Like. Yet another company has walked away or not interested in parsortix. T
Ramp as much as you like, EC has been doing it for over a year now without success.
I haven't seen anyone on here address the issues that now fave the company, lack of funds, huge losses, no management team etc so to think this looks a good investment you must be barking.
Reducing the losses by getting rid of staff ,the biggest factor in their losses will cost millions in redundancy and wipe out what cash they have left in all probability . Now explain how they will fund ongoing operations .